Gilliland Jeter Wealth Management LLC Purchases Shares of 4,262 IQVIA Holdings Inc. (NYSE:IQV)

Gilliland Jeter Wealth Management LLC purchased a new stake in IQVIA Holdings Inc. (NYSE:IQV) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 4,262 shares of the medical research company’s stock, valued at approximately $986,000.

A number of other large investors have also recently bought and sold shares of the stock. AdvisorNet Financial Inc boosted its stake in IQVIA by 327.6% in the fourth quarter. AdvisorNet Financial Inc now owns 124 shares of the medical research company’s stock worth $29,000 after purchasing an additional 95 shares in the last quarter. BKM Wealth Management LLC acquired a new position in IQVIA in the fourth quarter worth $32,000. Activest Wealth Management acquired a new position in IQVIA in the fourth quarter worth $35,000. CVA Family Office LLC acquired a new position in IQVIA in the fourth quarter worth $43,000. Finally, CoreFirst Bank & Trust acquired a new position in IQVIA in the third quarter worth $44,000. 89.62% of the stock is currently owned by institutional investors.

IQVIA Trading Up 0.4 %

Shares of IQVIA stock traded up $0.90 during trading hours on Friday, hitting $234.88. The company’s stock had a trading volume of 697,640 shares, compared to its average volume of 761,918. IQVIA Holdings Inc. has a 12 month low of $167.42 and a 12 month high of $261.73. The stock has a 50 day moving average of $245.28 and a 200 day moving average of $223.17. The company has a market capitalization of $42.63 billion, a PE ratio of 32.22, a price-to-earnings-growth ratio of 2.27 and a beta of 1.50. The company has a debt-to-equity ratio of 2.12, a current ratio of 0.86 and a quick ratio of 0.86.

IQVIA (NYSE:IQV) last announced its quarterly earnings results on Wednesday, February 14th. The medical research company reported $2.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.82 by $0.02. IQVIA had a return on equity of 29.32% and a net margin of 9.06%. The company had revenue of $3.87 billion during the quarter, compared to the consensus estimate of $3.80 billion. During the same period in the prior year, the company earned $2.54 earnings per share. The company’s revenue for the quarter was up 3.5% compared to the same quarter last year. Analysts predict that IQVIA Holdings Inc. will post 10.12 earnings per share for the current year.

Wall Street Analysts Forecast Growth

IQV has been the topic of several research reports. Barclays upped their price target on IQVIA from $260.00 to $265.00 and gave the company an “overweight” rating in a research note on Thursday, February 15th. StockNews.com raised IQVIA from a “hold” rating to a “buy” rating in a research note on Friday, February 16th. SVB Leerink initiated coverage on IQVIA in a research note on Monday, February 26th. They set an “outperform” rating and a $290.00 price target on the stock. Truist Financial upped their price target on IQVIA from $286.00 to $297.00 and gave the company a “buy” rating in a research note on Tuesday, February 27th. Finally, Leerink Partnrs reaffirmed an “outperform” rating on shares of IQVIA in a research note on Monday, February 26th. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $256.80.

Insider Buying and Selling

In related news, insider Kevin C. Knightly sold 8,607 shares of the stock in a transaction dated Wednesday, February 28th. The stock was sold at an average price of $250.17, for a total transaction of $2,153,213.19. Following the completion of the transaction, the insider now directly owns 5,251 shares in the company, valued at $1,313,642.67. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other IQVIA news, insider Eric Sherbet sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $241.50, for a total value of $241,500.00. Following the completion of the transaction, the insider now directly owns 20,836 shares in the company, valued at $5,031,894. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Kevin C. Knightly sold 8,607 shares of the firm’s stock in a transaction that occurred on Wednesday, February 28th. The shares were sold at an average price of $250.17, for a total value of $2,153,213.19. Following the completion of the transaction, the insider now owns 5,251 shares of the company’s stock, valued at $1,313,642.67. The disclosure for this sale can be found here. Over the last three months, insiders sold 41,285 shares of company stock worth $10,331,003. 1.60% of the stock is owned by corporate insiders.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.